Tympanoseal
DeviceAll subjects will receive the Tympanoseal device that will be placed during a surgical procedure
NCT Number: NCT05849844
The purpose of this investigational study is to assess the ability of Tympanoseal (sodium/calcium alginate), an investigational device, to act as a scaffold during healing of the tympanic membrane. Tympanoseal is intended for use following removal or extrusion of indwelling tympanostomy tubes or traumatic injury of the tympanic membrane.
Interested in participating?
Request Info2 year–100 year
All sexes
Interventional
Not applicable
Michigan Ear Institute, Farmington Hills, Michigan, United States
This study will provide data on the safety and the ability of sodium/calcium alginate gels to act as a scaffold capable of occluding a tympanic membrane perforation over the duration of complete healing. Tympanoseal could be used in cases where cartilage or fat graft tympanoplasty would be indicated.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
All subjects will receive the Tympanoseal device that will be placed during a surgical procedure
Time frame: 12 weeks
The purpose of this investigational study is to assess the safety of Tympanoseal when used during the healing process. Subject will be observed during the study and the the healing process of the tympanic membrane. Information will be gathered via report forms during regular visits of the patient to the investigator.
Time frame: 12 weeks
Determine if any adverse events occur during presence of material on tympanic membrane.
Contact information is provided by the study sponsor or research team.
Grace Medical, Inc.
Industry
Tympanoseal (Tympanic Membrane Device) Clinical Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06260618
Ear Diseases, Otitis
Adelaide, South Australia, Australia
View Trial DetailsNCT07698171
Ear Diseases, Myringoplasty
Holon, Israel
View Trial DetailsNCT07535827
Ear Diseases, Glucose Metabolism Disorders
Minya, Egypt
View Trial DetailsNCT07595484
Chronic Otitis Media, Ear Diseases
Lahore, Punjab Province, Pakistan
View Trial Details